Suppressive effects of RASAL2 on renal cell carcinoma via SOX2/ERK/p38 MAPK pathway

Metastatic renal cell carcinoma (RCC) is associated with poor prognosis. Ras protein activator like 2 (RASAL2) protein has been previously demonstrated to serves as a tumor suppressor in a variety of malignancies. Therefore, the aim of the present study was to investigate the role of RASAL2 in RCC....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Sen, Hao, Xiaomin, He, Sai, Liu, Changli, Wang, Qilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571372/
https://www.ncbi.nlm.nih.gov/pubmed/33093889
http://dx.doi.org/10.3892/etm.2020.9280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571372/
https://www.ncbi.nlm.nih.gov/pubmed/33093889
http://dx.doi.org/10.3892/etm.2020.9280

Ejemplares similares